References

Antibiotics: past, present and future

10.1016/j.mib.2019.10.008 · 2019 · External reference

The bioavailability of drugs – the current state of knowledge

10.3390/molecules28248038 · 2023 · External reference

Subcutaneously administered antibiotics: a review

10.1093/jac/dkac383 · 2022 · External reference

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

2022 · External reference

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

10.1016/s1473-3099(19)30574-2 · 2020 · External reference

Absorption sites of orally administered drugs in the small intestine

10.1080/17460441.2017.1378176 · 2017 · External reference

The effect of bariatric surgery on oral antibiotic absorption: a systematic review

10.1007/s11695-020-04623-z · 2020 · External reference

Together or apart? Revealing the impact of dietary interventions on bioavailability of quinolones: a systematic review with meta-analyses

10.1007/s40262-024-01377-0 · 2024 · External reference

Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses

10.1093/jac/dkae028 · 2024 · External reference

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of clostridioides difficile infection in adults

10.1093/cid/ciab549 · 2021 · External reference

Enhancing antibiotic therapy through comprehensive pharmacokinetic/pharmacodynamic principles

10.3389/fcimb.2025.1521091 · 2025 · External reference

Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices

10.1016/j.ijantimicag.2010.01.023 · 2010 · External reference

Seventy-five years of research on protein binding

10.1128/aac.01663-17 · 2018 · External reference

Intracellular pharmacokinetics of antibacterials and their clinical implications

10.1007/s40262-017-0572-y · 2018 · External reference

Clinical pharmacokinetics of antibacterials in cerebrospinal fluid

10.1007/s40262-013-0062-9 · 2013 · External reference

A systematic review of studies reporting antibiotic pharmacokinetic data in the cerebrospinal fluid of critically ill patients with uninflamed meninges

10.1128/aac.01998-20 · 2020 · External reference

Antibiotic penetration into bone and joints: an updated review

10.1016/j.ijid.2019.02.005 · 2019 · External reference

Drug transporters and metabolizing enzymes in antimicrobial drug pharmacokinetics: mechanisms, drug-drug interactions, and clinical implications

10.3390/biom15060864 · 2025 · External reference

Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management

10.1002/phar.2672 · 2022 · External reference

Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR

10.34067/kid.0003202022 · 2022 · External reference

β-Lactam dosage regimens in septic patients with augmented renal clearance

10.1128/aac.02534-17 · 2018 · External reference

Clinical pharmacology of antibiotics

10.2215/cjn.08140718 · 2019 · External reference

Identifying modulators of the post-antibiotic effect

10.1021/acsinfecdis.5c00424 · 2025 · External reference

Prolonged vs intermittent infusions of β-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis

10.1001/jama.2024.9803 · 2024 · External reference

Extended and continuous infusion of novel protected β-lactam antibiotics: a narrative review

10.1007/s40265-023-01893-6 · 2023 · External reference

Pharmacological considerations for the proper clinical use of aminoglycosides

10.2165/11597020-000000000-00000 · 2011 · External reference

Aminoglycosides: single- or multiple-daily dosing? An updated qualitative systematic review of randomized trials on toxicity and efficacy

10.2174/1566524023666230801160452 · 2024 · External reference

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones

10.1086/428053 · 2005 · External reference

Pharmacokinetics and pharmacodynamics of peptide antibiotics

10.1016/j.addr.2022.114171 · 2022 · External reference

Optimizing the clinical use of vancomycin

10.1128/aac.03147-14 · 2016 · External reference

Macrolides: pharmacokinetics and pharmacodynamics

10.1016/s0924-8579(01)00406-x · 2001 · External reference

10.1002/phar.2376

10.1002/phar.2376 · 2020 · External reference

Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

10.3390/pharmaceutics14030489 · 2022 · External reference

Emergence and spread of antibiotic resistance following exposure to antibiotics

10.1111/j.1574-6976.2011.00295.x · 2011 · External reference

Mutant prevention concentration, frequency of spontaneous mutant selection, and mutant selection window – a new approach to the in vitro determination of the antimicrobial potency of compounds

10.1128/aac.01373-22 · 2023 · External reference

Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review

10.1016/j.micres.2022.127221 · 2023 · External reference

Multidrug resistant Pseudomonas aeruginosa in clinical settings: a review of resistance mechanisms and treatment strategies

10.3390/pathogens13110975 · 2024 · External reference

Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors

10.2174/1381612043383377 · 2004 · External reference

Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa

10.1378/chest.125.2_suppl.62s · 2004 · External reference

Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli

10.1038/s41598-020-65602-z · 2020 · External reference

Inoculum effect of β-lactam antibiotics

10.1093/jac/dkz226 · 2019 · External reference

In vitro and in vivo activities of piperacillin–tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae

10.1111/1469-0691.12677 · 2014 · External reference

Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review

10.1093/jacamr/dlae069 · 2024 · External reference

Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula

10.1038/s41598-025-90762-1 · 2025 · External reference

The emerging role of β-lactams in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections

10.1128/aac.00468-20 · 2020 · External reference

The eagle effect and antibiotic-induced persistence: two sides of the same coin?

10.1016/j.tim.2018.10.007 · 2019 · External reference

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections – a systematic review and meta-analysis

10.1016/j.cmi.2017.06.017 · 2018 · External reference

ESCMID guideline for the diagnosis and treatment of biofilm infections 2014

10.1016/j.cmi.2014.10.024 · 2015 · External reference

Treatment of bacterial infections with β-lactams: cooperation with innate immunity

10.1128/iai.00503-22 · 2023 · External reference

Unresolved reference

2025 · External reference

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

10.1097/ccm.0000000000005337 · 2021 · External reference

Continuous versus intermittent infusion of vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis

10.1097/ccm.0000000000004326 · 2020 · External reference

Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update

10.1177/1060028019865873 · 2020 · External reference

2023 ESC guidelines for the management of endocarditis

10.1093/eurheartj/ehad193 · 2023 · External reference

Intrathecal antibacterial and antifungal therapies

10.1128/cmr.00190-19 · 2020 · External reference

Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies

10.1016/j.ijantimicag.2013.09.002 · 2013 · External reference

A review of antibiotic safety in pregnancy – 2025 update

10.1002/phar.70010 · 2025 · External reference

Expert consensus statement on therapeutic drug monitoring and individualization of linezolid

10.3389/fpubh.2022.967311 · 2022 · External reference

Fixed dose daptomycin: an opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections

10.1002/phar.4602 · 2024 · External reference

A guide to therapeutic drug monitoring of β-lactam antibiotics

10.1002/phar.2505 · 2021 · External reference